Rydar Equities’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Rydar Equities's NVS Position: Q2 2026 in Review
Rydar Equities opened a new position in Novartis (NVS) in Q2 2026: 2,630 shares worth $403K. The stake represents 0.23% of the portfolio and ranks #78 among its holdings. This is a return to the name: Rydar Equities previously reported a position in NVS as recently as Q2 2025.
Rydar Equities first reported a position in NVS in Q2 2025 and has held it in 2 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Rydar Equities held 2,630 shares of Novartis worth $403K as of Q2 2026.
- Novartis was a new Rydar Equities position in Q2 2026.
- Novartis made up 0.23% of Rydar Equities's portfolio in Q2 2026, its #78 holding.
- Rydar Equities first reported a position in Novartis in Q2 2025 and has held it in 2 quarters since.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Rydar Equities's 13F filing for Q2 2026, filed 21 Jul 2026.